AI ‘Fragle’ Method Makes Cancer Tracking More Efficient
Researchers have developed an AI blood test called Fragle to accurately and affordably track cancer treatment response and detect relapse.
Read More
Search Results for: liver disease
Access Medical Labs Transitions to Roche Diagnostics
Access Medical Labs has fully transitioned to Roche Diagnostics equipment in under 30 days, increasing testing speed, capacity & efficiency.
Read More
Quest Diagnostics to Develop MCaST Blood Test
Quest Diagnostics is partnering with MD Anderson Cancer Center to develop a lab-based blood test for cancer that uses protein biomarkers.
Read More
Collaboration Expanded to Accelerate Progress in MASH Diagnosis
Echosens and Boehringer Ingelheim have expanded their partnership to improve early detection, diagnosis, and care access for MASH.
Read More
Liquid Biopsy Launched at Florida Cancer Institute
Florida Cancer Specialists & Research Institute now offers liquid biopsy, a minimally invasive blood test that enhances cancer diagnosis.
Read More